Immunotherapeutic strategies for the treatment of renal cell carcinoma: Where will we go?

Da Costa, Ines Anselmo; Rausch, Steffen; Kruck, Stephan; Todenhoefer, Tilman; Stenzl, Arnulf; Bedke, Jens

dc.contributor.author	Anselmo da Costa, Inês
dc.contributor.author	Rausch, Steffen
dc.contributor.author	Kruck, Stephan
dc.contributor.author	Stenzl, Arnulf
dc.contributor.author	Bedke, Jens
dc.contributor.author	Todenhöfer, Tilman Wolfgang
dc.date.accessioned	2018-03-06T12:35:23Z
dc.date.available	2018-03-06T12:35:23Z
dc.date.issued	2017
dc.identifier.issn	1744-8328
dc.identifier.uri	http://hdl.handle.net/10900/80925
dc.language.iso	en	en
dc.publisher	Taylor & Francis Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1080/14737140.2017.1292138	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Immunotherapeutic strategies for the treatment of renal cell carcinoma: Where will we go?	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_01235
utue.publikation.seiten	357-368	de_DE
utue.personen.roh	Da Costa, Ines Anselmo
utue.personen.roh	Rausch, Steffen
utue.personen.roh	Kruck, Stephan
utue.personen.roh	Todenhoefer, Tilman
utue.personen.roh	Stenzl, Arnulf
utue.personen.roh	Bedke, Jens
dcterms.isPartOf.ZSTitelID	Expert Review of Anticancer Therapy	de_DE
dcterms.isPartOf.ZS-Issue	4	de_DE
dcterms.isPartOf.ZS-Volume	17	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE